Transplant stories

Real Treatments. Real Families. Real Hope.

Smart Cells was the first private UK stem cell bank to release samples for transplant — proving that family cord blood banking is not just about storage, but about delivering real therapies when they are needed most.

Why Stem Cell Transplants Matter

At some point in life, your child or family member may need access to stem cell therapy. Today, these treatments are being used for:

Blood cancers such as leukaemia and lymphoma
Inherited genetic disorders including thalassemia and sickle cell disease
Neurological conditions such as cerebral palsy and brain injury
Immune deficiencies and metabolic disorders
Emerging therapies for sports injuries, inflammatory conditions, and skin repair

By preserving your baby’s umbilical cord blood and tissue, you safeguard access to these life-saving and life-enhancing possibilities.

Proven Track Record

Smart Cells has released more stem cell samples for treatment than any other private UK bank, with a 100% success rate for every sample delivered to clinicians worldwide.

These samples have helped children and families across the globe face illnesses such as:

Cerebral Palsy
Thalassemia
Leukaemia
HSV Encephalitis
Immune system disorders

Each transplant is more than a statistic — it represents a child given new options, and a family given hope.

A Milestone for Families and for Science

Every successful release shows how far the field of stem cell research has advanced. What was once only a possibility is now a proven therapy.

Yet many parents are still unaware of the benefits of storing their baby’s cord blood and tissue. Smart Cells is working to change that — by raising awareness, sharing real transplant stories, and supporting research into the next generation of regenerative treatments.

Powered by FamiCord: Europe’s Stem Cell Leader in banking and use of cells

As part of the FamiCord Group, Europe’s largest family stem cell bank and one of the world’s top three:

Families gain access to 1,000,000+ stored cord blood units across the network
Therapies are supported by specialist research centres and clinical teams in 35+ countries including FamiCord Programme for brain disorders
FamiCordTx, the group’s advanced therapies division, is actively developing new cell-based treatments to extend the possibilities for families everywhere

Together, Smart Cells and FamiCord stand at the forefront of innovation, offering parents confidence today — and hope for tomorrow.

Order now Find out more

FamiCord Group releases

Patients

7800+

Expand table
No.	Source	Source type	Diagnosis	Medical sector	Year of application	Therapy	Country	Age of the recipient
8601	Bone Marrow	Autologous	Coronary Artery Disease; Cardiomyopathy	Hematology	2010	Standard Therapy	Germany	52
8602	Bone Marrow	Autologous	Dilated Cardiomyopathy	Hematology	2010	Standard Therapy	Germany	67
8603	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2010	Standard Therapy	Germany	70
8604	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2010	Standard Therapy	Germany	49
8605	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2010	Standard Therapy	Germany	48
8606	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2010	Standard Therapy	Germany	50
8607	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2010	Standard Therapy	Germany	54
8608	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2010	Standard Therapy	Germany	73
8609	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2010	Standard Therapy	Germany	47
8610	Bone Marrow	Autologous	Myocardial Infarction	Hematology	2010	Standard Therapy	Germany	51
8611	Bone Marrow	Autologous	Myocardial Infarction	Hematology	2010	Standard Therapy	Germany	54
8612	Bone Marrow	Autologous	Myocardial Infarction	Hematology	2010	Standard Therapy	Germany	51
8613	Bone Marrow	Autologous	Peripheral Artery Disease	Hematology	2010	Standard Therapy	Germany	56
8614	Bone Marrow	Autologous	Peripheral Artery Disease With Ulcer	Hematology	2010	Standard Therapy	Germany	79
8615	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2010	Standard Therapy	Germany	26
8616	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2010	Standard Therapy	Germany	64
8617	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2010	Standard Therapy	Germany	47
8618	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2010	Standard Therapy	Germany	44
8619	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2010	Standard Therapy	Germany	48
8620	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2010	Standard Therapy	Germany	59
8621	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2010	Standard Therapy	Germany	50
8622	Apheresis	Allogeneic	Acute Myeloid Leukemia; Myelodysplastic Syndrome	Hematology	2010	Standard Therapy	Germany	66
8623	Apheresis	Allogeneic	Atypical Myelodysplastic Syndrome	Hematology	2010	Standard Therapy	Germany	25
8624	Apheresis	Allogeneic	B-Cell Chronic Lymphoblastic Leukemia	Hematology	2010	Standard Therapy	Germany	56
8625	Apheresis	Autologous	B-Cell Non-Hodgkin Lymphoma	Hematology	2010	Standard Therapy	Germany	54
8626	Apheresis	Autologous	B-Cell Non-Hodgkin Lymphoma – Relapse	Hematology	2010	Standard Therapy	Germany	52
8627	Apheresis	Autologous	B-Cell Non-Hodgkin Lymphoma – Relapse	Hematology	2010	Standard Therapy	Germany	45
8628	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2010	Standard Therapy	Germany	57
8629	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2010	Standard Therapy	Germany	43
8630	Apheresis	Autologous	Diffuse Large B-Cell Non-Hodgkin-Lymphoma	Hematology	2010	Standard Therapy	Germany	57
8631	Apheresis	Autologous	Extramedullary Plasmacytoma	Hematology	2010	Standard Therapy	Germany	48
8632	Apheresis	Allogeneic	Mantle Cell Lymphoma	Hematology	2010	Standard Therapy	Germany	61
8633	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2010	Standard Therapy	Germany	72
8634	Apheresis	Allogeneic	Mantle Cell Lymphoma	Hematology	2010	Standard Therapy	Germany	53
8635	Apheresis	Autologous	Morbus Hodgkin	Hematology	2010	Standard Therapy	Germany	29
8636	Apheresis	Autologous	Morbus Hodgkin-Relapse	Hematology	2010	Standard Therapy	Germany	21
8637	Apheresis	Autologous	Morbus Hodgkin-Relapse	Hematology	2010	Standard Therapy	Germany	23
8638	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	43
8639	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	57
8640	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	62
8641	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	45
8642	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	47
8643	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	52
8644	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	52
8645	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	67
8646	Apheresis	Allogeneic	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	55
8647	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	57
8648	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	51
8649	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	53
8650	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	69
8651	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	58
8652	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	70
8653	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	64
8654	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	69
8655	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	68
8656	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	63
8657	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	61
8658	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	56
8659	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	68
8660	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	52
8661	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	60
8662	Apheresis	Autologous	Multiple Myeloma	Hematology	2010	Standard Therapy	Germany	64
8663	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2010	Standard Therapy	Germany	70
8664	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2010	Standard Therapy	Germany	57
8665	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2010	Standard Therapy	Germany	60
8666	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2010	Standard Therapy	Germany	33
8667	Apheresis	Allogeneic	Myelodysplastic Syndrome; Acute Myelogenous Leukemia	Hematology	2010	Standard Therapy	Germany	54
8668	Apheresis	Autologous	Non-Hodgkin-Lymphoma-Relapse	Hematology	2010	Standard Therapy	Germany	48
8669	Apheresis	Autologous	Non-Hodgkin-Lymphoma-Relapse	Hematology	2010	Standard Therapy	Germany	44
8670	Apheresis	Autologous	Primary Central Nervous System Lymphoma	Hematology	2010	Standard Therapy	Germany	66
8671	Apheresis	Allogeneic	Primary Myelofibrosis	Hematology	2010	Standard Therapy	Germany	60
8672	Apheresis	Allogeneic	Primary Myelofibrosis	Hematology	2010	Standard Therapy	Germany	59
8673	Apheresis	Allogeneic	Secondary Acute Myeloid Leukemia	Hematology	2010	Standard Therapy	Germany	48
8674	Apheresis	Autologous	T-Cell Non-Hodgkin Lymphoma	Hematology	2010	Standard Therapy	Germany	61
8675	Apheresis	Allogeneic	T-Cell Non-Hodgkin Lymphoma	Hematology	2010	Standard Therapy	Germany	41
8676	Apheresis	Allogeneic	T-Cell Non-Hodgkin Lymphoma Relapse	Hematology	2010	Standard Therapy	Germany	43
8677	Apheresis	Autologous	T-Cell-Lymphoma	Hematology	2010	Standard Therapy	Germany	49
8678	Apheresis	Autologous	Testicular Carcinoma	Hematology	2010	Standard Therapy	Germany	39
8679	Cord Blood	Allogeneic – Related	Acute Lymphoblastic Leukemia	Hematology	2009	Standard Therapy	Germany	10
8680	Cord Blood	Allogeneic – Related	Beta Thalassemia	Hematology	2009	Standard Therapy	Germany	10
8681	Cord Blood	Autologous	Brain Damage	Neurology	2009	Experimental Therapy	Germany	2
8682	Cord Blood	Autologous	Brain Damage	Neurology	2009	Experimental Therapy	Germany	4 months
8683	Cord Blood	Autologous	Cerebral Palsy	Neurology	2009	Experimental Therapy	Portugal	2
8684	Cord Blood	Autologous	Cerebral Palsy	Neurology	2009	Experimental Therapy	Portugal	2
8685	Cord Blood	Autologous	Cerebral Palsy	Neurology	2009	Experimental Therapy	UK	3
8686	Cord Blood	Allogeneic – Related	Myelodysplastic Syndrome	Hematology	2009	Standard Therapy	Poland	5
8687	Cord Blood	Allogeneic – Related	Thalassemia Major	Hematology	2009	Standard Therapy	Turkey	12
8688	Cord Blood	Autologous	Typ-1-Diabetes	Endocrinology	2009	Experimental Therapy	Germany	3
8689	Cord Blood	Autologous	Typ-1-Diabetes	Endocrinology	2009	Experimental Therapy	Germany	3
8690	Cord Blood	Autologous	Typ-1-Diabetes	Endocrinology	2009	Experimental Therapy	Germany	3
8691	Bone Marrow	Autologous	Cardiomyopathy	Hematology	2009	Standard Therapy	Germany	67
8692	Bone Marrow	Autologous	Cardiomyopathy	Hematology	2009	Standard Therapy	Germany	50
8693	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2009	Standard Therapy	Germany	49
8694	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2009	Standard Therapy	Germany	64
8695	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2009	Standard Therapy	Germany	55
8696	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2009	Standard Therapy	Germany	56
8697	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2009	Standard Therapy	Germany	46
8698	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2009	Standard Therapy	Germany	46
8699	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2009	Standard Therapy	Germany	63
8700	Bone Marrow	Autologous	Myocardial Infarction	Hematology	2009	Standard Therapy	Germany	57

Page 87 of 89 1 85 86 87 88 89

Expand table

Stem cell transplantation has become an established procedure

700,000

cord blood collections have been undertaken globally

50,000

hematopoietic stem cell transplants take place every year

400/500

of these transplants are in Europe

Our transplant stories

Smart Cells have released 24 UK
samples to six countries.

Stem cells hold the key to more than 80 life-changing treatments, with clinical trials underway on many more. Replacing damaged cells and tissue, they can even save a child’s life.

100% infusion success rate

For samples released for transplant.

3 months – 12 yrs old

Stored cord blood samples have been successfully released for use in transplant for children aged as little as 3 months to 12 years old.

46% self | 54% siblings

Smart Cells have successfully released stored cord blood samples that have been used for treatment with the child it was collected from and also siblings.

Smart Cells releases

UK samples released

Expand table
Sample release date	Medical condition	Recipient relationship	Age of the recipient	Unit volume	Medical center	Country
2005.11	Thalassemia	Allogeneic (Sibling)	4 Years	144ml	Mount Vernon Hospital	Singapore
2005.11	Leukaemia	Allogeneic (Sibling)	Restricted	Restricted	Stem Cells and Immunology Department, Birmingham	UK
2007.02	Thalassemia	Allogeneic (Sibling)	7 Years	76ml	Kinderlink der Tu Munchen	Germany
2009.08	Cerebral Palsy	Autologous (Self)	3 Years	51ml	Duke University, North Carolina	USA
2010.01	Cerebral Palsy	Autologous (Self)	3 Years	81ml	Duke University, North Carolina	USA
2013.10	Thalassemia	Allogeneic (Sibling)	5 Years	58ml	Catherine Lewis Centre, Hammersmith	UK
2014.01	Leukaemia	Allogeneic (Sibling)	4 Years	71ml	Medizinische Hochschule, Hanover	Germany
2014.05	Cerebral Palsy	Autologous (Self)	1 year	68ml	Duke University, North Carolina	USA
2014.06	HSV Encephalitis & NMDA Receptor Antibody Virus	Autologous (Self)	2 Years	57ml	Duke University, North Carolina	USA
2014.08	Hypoxic Ischemic Encephalopathy (HIE)	Autologous (Self)	3 Months	39ml	Duke University, North Carolina	USA
2015.02	Hypoxic Ischemic Encephalopathy (HIE)	Autologous (Self)	6 Months	53ml	Duke University, North Carolina	USA
2015.03	Severe Combined Immune Deficiency	Autologous (Self)	3 Months	74ml	Duke University, North Carolina	USA
2015.03	Sickle Cell Disease	Allogeneic (Sibling)	2 .5 Years	57ml	BLK Hospital, New Delhi	India
2015.11	Thalassemia	Allogeneic (Sibling)	12 Years	87ml	Children’s Hospital of Pittsburgh of UPMC	USA
2016.03	Cerebral Palsy	Allogeneic (Sibling)	6 Years	101ml	Duke University, North Carolina	USA
2017.04	Lymphoblastic Leukaemia (^1)	N/A (Identical twin girls)	Restricted	125ml	Bambin Gesu Childrens’ Hospital, Rome	Italy
2017.06	Cerebral Palsy	Autologous (Self)	7 Years	82ml	Duke University, North Carolina	USA
2017.06	Cerebral Palsy	Autologous (Self)	3.4 Years	132ml	Duke University, North Carolina	USA
2018.03	Autism	Autologous (Self)	5.4 Years	73ml	Duke University, North Carolina	USA
2018.03	Cerebral Palsy	Autologous (Self)	3.4 years	132ml	Duke University, North Carolina	USA
2019.06	Cerebral Palsy	Allogeneic (Sibling)	3 Years	104ml	Duke University, North Carolina	USA
2022.02	Cerebral Palsy	Allogeneic (Sibling)	11 Years	185ml	Duke University, North Carolina	USA
2023.08	Cerebral Palsy	Allogeneic (Sibling)	3 Years	46ml	Duke University, North Carolina	USA
2024.01	Thalassaemia	Allogeneic (Sibling)	8 Years	45ml	Cincinnati Children’s Hospital Medical Center	USA